ArticleJournal of neuromuscular diseasesPublished
Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Article
- Venue
- Journal of neuromuscular diseases
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Muscular Dystrophy, Duchenne; Dystrophin; Antibodies, Monoclonal; Connective Tissue Growth Factor; Antibodies, Monoclonal, Humanized; Monoclonal antibody; Connective tissue growth factor; Duchenne muscular dystrophy; Clinical Trial; Grip Strength; Percent Predicted Forced Vital Capacity
- PubMed ID
- 37248912
- PubMed Central ID
- PMC10357134
- Open access
- Yes, open
- Added to directory
- Source checked